HPV legislation in Alabama
Contents
Women in Government Ratings
Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" [1]:
POPULATION: 4,599,030
Incidence & Mortality (2008 Score / 2007 Score)
- Cervical Cancer Incidence Rate: 8.4/100,000 (1/ 1)
- Cervical Cancer Incidence Rate/Race: White: 7.7 , Black: 10.7
- Cervical Cancer Mortality Rate: 3.0/100,000 (1 / 1)
- Cervical Cancer Mortality Rate/Race: White: 2.3 , Black: 5.5
Screening (2008 Score / 2007 Score)
- Cervical Cancer Screening Rate: 83.4% (1 / 2)
- Cervical Cancer Screening Rate/Race: White: 83.5%, Black: 84%
- % Uninsured/Unscreened: 18.8% (2 / 2)
- Medicaid Coverage HPV Testing: Unrestricted (2 / 2)
Healthcare Access (2008 Score / 2007 Score)
- Rate Uninsured Women: 19% (1 / 1)
- % Low Income/Uninsured Women: 34%
Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)
Screening Requirements
- There are no new screening requirements. (0 / 1)
Task Forces (0 / 1)
- There is no new cervical cancer prevention task force legislation.
Access to HPV Vaccines (0 / 0)
- There is no HPV vaccine activity.
HPV Vaccine Information Programs (0 / 0)
- There is no HPV vaccine information activity.
Miscellaneous (0 / 2)
- There is no new miscellaneous cervical cancer prevention activity.
Additional Notes
- State health officials had hoped to receive $4 million from the Legislature to make the HPV vaccine available to 10,000 girls and teens, but money was not available.
Annual Ratings
- 2008: Good (12 out of 22 points)
- 2007: Very Good (13 out of 18 points)
Articles and resources
SourceWatch Resources
- Gardasil
- GlaxoSmithKline
- Merck
- Women in Government
- Edelman
- The Marketing of Gardasil in Australia
- The Marketing of Gardasil in Canada
- The Marketing of Gardasil in Europe
- The Marketing of Gardasil in New Zealand
- The Marketing of Gardasil in the United States
- Direct-to-consumer advertising
- Disease Mongering
- Drug industry
External links
- Judith Siers-Poisson, The Politics and PR of Cervical Cancer, a four part series, PRWatch.org, July, 2007.
References
- ↑ "The 'State' of Cervical Cancer Prevention in America - 2008", Women in Government